<?xml version="1.0" encoding="UTF-8"?>
<table-wrap position="float" id="tbl3">
 <label>Table 3</label>
 <caption>
  <p>Hepatitis E infection in immunocompetent and immunocompromised individuals</p>
 </caption>
 <table frame="hsides" rules="groups">
  <thead>
   <tr>
    <th/>
    <th>Immunocompetent</th>
    <th>Immunocompromised</th>
   </tr>
  </thead>
  <tbody>
   <tr>
    <td colspan="3">Presentation</td>
   </tr>
   <tr>
    <td> Symptoms</td>
    <td>Self-limited, nonspecific symptoms</td>
    <td>Typically asymptomatic</td>
   </tr>
   <tr>
    <td> ALT Level</td>
    <td>High &gt;1000 IU/L</td>
    <td>Moderate 100–300 IU/L</td>
   </tr>
   <tr>
    <td> Extrahepatic Manifestations</td>
    <td colspan="2">Neurologic: Guillain-Barré syndrome, radiculoneuropathy, amyotrophy, encephalitis
     <break/>Renal: membranous and membranoproliferative glomerulonephritis, IgA nephropathy
     <break/>Hematologic: aplastic anemia, autoimmune hemolytic anemia, cryoglobulinemia, thrombocytopenia
     <break/>Pancreatic: pancreatitis
     <break/>Rheumatologic: polyarthritis
     <break/>Cardiac: myocarditis
     <break/>Endocrine: thyroiditis
    </td>
   </tr>
   <tr>
    <td colspan="3">Diagnosis</td>
   </tr>
   <tr>
    <td> Serologies</td>
    <td>HEV IgM and/or HEV RNA</td>
    <td>HEV RNA</td>
   </tr>
   <tr>
    <td> Liver Biopsy</td>
    <td>Varies: mixed inflammatory infiltrate, interface hepatitis, cholestasis, apoptotic bodies</td>
    <td>Varies: minimal inflammation, mild acute cellular rejection</td>
   </tr>
   <tr>
    <td> Differential Diagnoses</td>
    <td>Acute viral hepatitis (HAV, HBV, HCV, HEV, CMV, EBV)
     <break/>Autoimmune hepatitis
     <break/>Drug-induced liver injury
    </td>
    <td>Acute cellular rejection (liver transplant patients)
     <break/>Graft-versus-host disease (SOT or SCT patients)
     <break/>Drug-induced liver injury
     <break/>Chronic viral hepatitis (HBV, HCV, HDV)
     <break/>EBV and CMV hepatitis (reactivation)
    </td>
   </tr>
   <tr>
    <td>Treatment</td>
    <td>None
     <break/>Consider treatment if extrahepatic manifestations or high risk; ie, pregnancy, chronic liver disease
    </td>
    <td>Reduction of immunosuppression (avoidance of calcineurin inhibitors)
     <break/>Ribavirin 600 mg for 3 mo, dose adjusted for weight and renal function
    </td>
   </tr>
   <tr>
    <td>Prevention</td>
    <td colspan="2">Universal access to clean drinking water
     <break/>Avoidance of undercooked pork, wild game, and shellfish
     <break/>Screening of blood donors and/or products
     <break/>Vaccination (currently not available in most countries)
    </td>
   </tr>
  </tbody>
 </table>
 <table-wrap-foot>
  <fn>
   <p>
    <italic>Abbreviations:</italic> CMV, cytomegalovirus; EBV, Epstein-Barr virus; HAV, hepatitis A virus; HCV, hepatitis C virus; IgA, immunoglobulin A; SOT, solid organ transplant; SCT, stem cell transplant.
   </p>
  </fn>
 </table-wrap-foot>
</table-wrap>
